Business
– Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor...
Hi, what are you looking for?
– Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor...
– With the hostile takeover saga of Botox-maker Allergan raging on for months, the situation has become even more complicated, with Actavis jumping...
Allergan, which has received a well-storied hostile takeover bid from Valeant Pharmaceutical, courtesy of hedge fund manager Bill Ackman is making acquisitions to show...
Daniel Och’s Oz Management has a new top holding Actavis Pharmaceutical (ACT) moved from the 4th spot last quarter to the number one position...
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
– – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to U.S. Patent 7, 132, 570...
– – Big Pharma is in trouble these days as the cost of researching and qualifying new drugs has risen rapidly, and in inverse...
– / By Clive Minchom / Valeant Pharmaceuticals International of Canada, and Bausch + Lomb Holdings Incorporated, a global eye care company based in Rochester...